![]() |
![]() ![]() ![]() |
|
|
REFERENCES 1. The world health report 2003: shaping the future. Geneva, World Health Organization, 2003. 2. Korenromp EL for the Roll Back Malaria Monitoring and Evaluation Reference Group & MERG Task Force on Malaria Morbidity. Malaria incidence estimates at country level for the year2004–proposed estimates and draft report. Geneva, Roll Back Malaria, World Health Organization, 2004. 3. Sachs JD. Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. Geneva, World Health Organization, December 2001. 4. Nabarro D, Taylor E. The "Roll Back Malaria" campaign. Science, 1998, 280:2067–2068. 5. Roll Back Malaria. Framework for monitoring progress and evaluating outcomes and impact. Geneva, World Health Organization, 2000 (WHO/CDS/RBM/2000.25). 6. Roll Back Malaria initiative in the African Region: monitoring and evaluation guidelines. Harare, World Health Organization Regional Office for Africa, 2000. 7. Monitoring and evaluation toolkit: HIV/AIDS, tuberculosis and malaria. Geneva, Global Fund to Fight AIDS, Tuberculosis and Malaria, June 2004. 8. The African summit on Roll Back Malaria, Abuja, Nigeria, 25 April 2000. Geneva, World Health Organization, 2000 (WHO/CDS/RBM/2000.17). 9. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva, World Health Organization, 2003 (WHO/HTM/RBM/2003.50). 10. Multiple Indicator Cluster Surveys (MICS-2)/End decade assessment. New York, NY, United Nations Children’s Fund, 2001. 11. Demographic and Health Surveys (DHS). Measure DHS. Calverton, ORC Macro, 2005. 12. NetMark. A regional partnership for sustainable malaria prevention. 13. Population Services International. 14. Nájera JA, Zaim M. Global insecticide use for vector-borne disease control. Geneva, World Health Organization, 2002 (WHO/CDS/WHOPES/2002.5). 15. WHO Expert Committee on Malaria. Twentieth report. Geneva, World Health Organization, 2000 (WHO Technical Report Series, No. 892). 16. Boyd MF. Malariology: a comprehensive survey of all aspects of this group of diseases from a global standpoint. Philadelphia, PA, WB Saunders, 1949. 17. Hay SI et al. The global distribution and population at risk of malaria: past, present, and future. Lancet Infectious Diseases, 2004, 4:327–336. 18. Korenromp EL et al. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infectious Diseases, 2003, 3(6):349–358. 19. Rowe AK et al. The burden of malaria mortality among African children in the year 2000 (submitted January 2005). 20. Korenromp EL et al. Monitoring trends in under-five mortality rates through national birth history surveys. International Journal of Epidemiology, 2004, 33(6):1293–1301. 21. Hay SI, Guerra CA, Snow RW. Determination of country populations at malaria risk of different endemicities: report on agreement to perform work (APW) for WHO/Roll Back Malaria. Oxford, Oxford University, Department of Zoology, TALA Research Group, August 2004 (M50/370/19). 22. Scaling-up home management of malaria: from research to implementation. Geneva, World Health Organization, 2003 (WHO/HTM/MAL/2004.1096). 23. Guillet P. Fifth update on long-lasting insecticidal nets: current status and programmatic issues. Geneva, World Health Organization, 5 January 2004. 24. Stockholm Convention on Persistent Organic Pollutants, 2004. 25. Thomson MC, Connor SJ. The development of malaria early warning systems for Africa. Trends in Parasitology, 2001, 17(9):438–445. 26. Roll Back Malaria. A practical guideline for prevention and control of malaria epidemics in Africa. Geneva, World Health Organization (draft in circulation, January 2003; DIP/MAL/03.06). 27. Strategic framework for malaria control during pregnancy in the WHO African Region. Geneva, World Health Organization, final draft, November 2002. 28. Ter Kuile FO et al. The burden of co-infection with HIV-1 and malaria in pregnant women in sub-Saharan Africa. American Journal of Tropical Medicine and Hygiene, 2004, 71(Suppl. 2):41–54. 29. Worrall E, Rietveld A, Delacollette C. The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa. American Journal of Tropical Medicine and Hygiene, 2004, 71(Suppl. 2):136–140. 30. Roll Back Malaria in the Eastern Mediterranean Region: achievements, challenges and the way forward. Cairo, World Health Organization Regional Office for the Eastern Mediterranean, 2004 (WHO-EM/MAL/305/E). 31. The Africa malaria report 2003. Geneva, World Health Organization/United Nations Children’s Fund, 25 April 2003 (WHO/CDS/MAL/2003.1093). 32. Nicoll A. Integrated management of childhood illness in resource-poor countries: an initiative from the World Health Organization. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000, 94(1):9–11. 33. Molineaux L. Malaria and mortality: some epidemiological considerations. Annals of Tropical Medicine and Parasitology, 1997, 91(7):811–825. 34. Steketee RW et al. The burden of malaria in pregnancy in malaria-endemic areas. American Journal of Tropical Medicine and Hygiene, 2001, 64(Suppl. 1, 2):28–35. 35. Lengeler, C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database of Systematic Reviews, 2004(3):CD000363. 36. The state of the world’s children 2005: childhood under threat. New York, NY, United Nations Children’s Fund, 2004. 37. Progress report on implementation of the Plan of Action of the Abuja Declaration. Harare, World Health Organization Regional Office for Africa/World Health Organization Regional Office for the Eastern Mediterranean, December 2004. 38. Kiszewski A et al. An estimate of the global cost of intensified antimalarial interventions. Boston, MA, Harvard School of Public Health, draft report, 14 February 2005. 39. Graves PM. Eritrea: malaria surveillance, epidemic preparedness, and control program strengthening. Activity Report 144. Washington, DC, Environmental Health Project, October 2004. 40. Craig MH et al. Exploring thirty years of malaria case data in KwaZulu-Natal, South Africa, Part II: the impact of non-climatic factors. Tropical Medicine and International Health, 2004, 9(12):1258–1266. 41. Korenromp EL et al. Malaria cases and deaths attributable to the HIV-1 epidemic in sub-Saharan African: a quantitative assessment at country level (submitted February 2005). 42. Grimwade KN et al. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS, 2004, 18(3):547–554. 43. Grimwade KN et al. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatric Infectious Disease Journal, 2003, 22(12):1057–1063. 44. Whitworth J, Hewitt K. Epidemiological evidence and policy implications of HIV/AIDS and malaria interactions in non-pregnant adults. Working paper No. 4 for WHO Technical consultation on malaria and HIV/AIDS interactions and policy implications. Geneva, World Health Organization, June 2004. 45. Kublin JG et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet, 2005, 365(9455):233–240. 46. Malaria and HIV/AIDS interactions and implications: conclusions of a technical consultation convened by WHO, 23–25 June 2004. Geneva, World Health Organization, 2004 (WHO/HIV/2004.08). 47. Nwanyanwu OC et al. Malaria and human immunodeficiency virus infection among male employees of a sugar estate in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997, 91(5):567–569. 48. Birku Y et al. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Ethiopian Medical Journal, 2002, 40(Suppl.1):17–26. 49. Kamya MR, Kigonya CN, McFarland W. HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children. AIDS, 2001, 15(9):1187–1188. 50. Ndayiragije A et al. Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi. Tropical Medicine and International Health, 2004, 9(6):673–679. 51. Kolaczinski JK et al. Malaria control in Afghanistan: progress and challenges. Lancet, published online 1 February 2005. 52. United Nations Population Division (UNPOP). World population prospects: the 2004 revision population databas. 53. Barcus MJ et al. Epidemic malaria in the Menoreh Hills of Central Java. American Journal of Tropical Medicine and Hygiene, 2002, 66(3):287–292. 54. Schapira A. Technical note: malaria risk and malaria control in Asian countries affected by the tsunami disaster. Draft 2. Geneva, Roll Back Malaria, World Health Organization, 25 January 2005. 55. Maitland K et al. Absence of malaria-specific mortality in children in an area of hyperendemic malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997, 91(5):562–566. 56. Ettling MB. The control of malaria in Viet Nam from 1980 to 2000: what went right? Manila, World Health Organization Regional Office for the Western Pacific, 2002. 57. International travel and health. Situation as of 1 January 2003. Geneva, World Health Organization, 2004. 58. Macroeconomics and health: investing in health for economic development. Commission on Macroeconomics and Health, chaired by JD Sachs, 20 December 2001. Geneva, World Health Organization, 2001 (Report no. 2001/13984). 59. Maputo declaration on HIV/AIDS, tuberculosis, malaria and other related infectious diseases. Assembly/AU/Decl.6 (II), Maputo, July 2003. Addis Ababa, The African Union. 60. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy, 2003, 63(1):17–36. 61. Ettling M et al. Economic impact of malaria in Malawian households. Tropical Medicine and Parasitology, 1994, 45(1):74–79. 62. The world health report 2004: changing history. Geneva, World Health Organization, 2004. 63. Zaim M, Jambulingam P. Global insecticide use for vector-borne disease control. Geneva, World Health Organization, 2004 (WHO/CDS/WHOPES/GCDPP/2000.9). 64. Malaria Medicines and Supplies Service. 65. Medicines for Malaria Venture. 66. Development of laboratory testing methods for malaria rapid diagnostic tests. Report of the WHO informal consultation on laboratory methods for quality assurance of malaria rapid diagnostic tests. Manila, World Health Organization Regional Office for the Western Pacific, July 2004. 67. Alonso PL et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet, 2004, 364(9443):1411–1420. 68. Malaria Vaccine Initiative. 69. Singhasivanon P. Mekong malaria: malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian Journal of Tropical Medicine and Public Health, 1999, 30(Suppl. 4):i–iv, 1–101. 70. The East African Network for Monitoring Antimalarial Treatment. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Tropical Medicine and International Health, 2001, 6(11):891–898. 71. The Horn of Africa Network for Monitoring Antimalarial Treatment, 2004. 72. Amazon Network for the Surveillance of Antimalarial Drug Resistance. 73. Korenromp EL et al. Impact of malaria control on childhood anaemia in Africa: a quantitative review. Tropical Medicine and International Health, 2004, 9(10):1050–1065. 74. Shah I et al. Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. Annals of Tropical Medicine and Parasitology, 1997, 91(6):591–602. 75. Kiszewski A et al. A global index representing the stability of malaria transmission. American Journal of Tropical Medicine and Hygiene, 2004, 70(5):486–498. 76. RBM MERG. Building capacity in monitoring and evaluating Roll Back Malaria in Africa: a conceptual framework for the Roll Back Malaria Partnership. Geneva, Roll Back Malaria Partnership. 77. Metselaar D, Van Thiel PM. Classification of malaria. Tropical and Geographic Medicine, 1959, 11:157–161. Additional resources are provided in Annex 6.
|
||